SFCM
BLTE

Seven Fleet Capital Management’s Belite Bio BLTE Stock Holding History

Seven Fleet Capital Management’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,161
Closed -$1.47M – 119
2025
Q4 		$1.47M Buy
+9,161
New +$1.09M 0.99% 18

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Seven Fleet Capital Management's BLTE Position: Q1 2026 in Review

Seven Fleet Capital Management sold out of Belite Bio (BLTE) in Q1 2026, closing a stake of 9,161 shares — an estimated $1.47M sold.

Seven Fleet Capital Management first reported a position in BLTE in Q4 2025 and held it in 1 quarter. The position peaked at $1.47M in Q4 2025. 75 funds tracked by Wall St. Rank hold BLTE as of Q1 2026.

  • Seven Fleet Capital Management reported no remaining Belite Bio position as of Q1 2026 after selling out during the quarter.
  • Seven Fleet Capital Management sold 9,161 Belite Bio shares in Q1 2026, an estimated $1.47M.
  • Seven Fleet Capital Management first reported a position in Belite Bio in Q4 2025 and held it in 1 quarter.
  • Seven Fleet Capital Management's Belite Bio position peaked at $1.47M in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Belite Bio as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.